Chinese medical journal
-
Chinese medical journal · Sep 2023
Meta AnalysisEfficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis.
Immune checkpoint inhibitors (ICIs) are standard treatments for advanced non-small cell lung cancer (NSCLC); however, evidence regarding their relative efficacy and safety is lacking. This study compared the efficacy and safety of all currently available ICI treatments in patients with advanced NSCLC to identify optimal treatment regimens. ⋯ PROSPERO, https://www.crd.york.ac.uk/PROSPERO/ , CRD42022323879.